Nobel prize winner and renowned researcher Michael Brown, MD, explains the process of developing new cancer treatments through translational research.
The OSI’s first major corporate gift is the fruit of a longstanding relationship between the two organizations.
Jennifer and John Wampler help fund emerging osteosarcoma research led by oncologist, Dr. Brian Crompton.
How a laser-focused approach is critical in accomplishing the Osteosarcoma Institute’s development goals.
Cigall Kadoch, PhD, a leading expert in gene regulation and an OSI board member, explains genetic mutations and how medicines may be able to reverse their cancer-causing impacts.
New research has led to the first diagnosis of advanced bone cancer in a dinosaur.